{"filings":[{"id":121362,"accession_number":"0001903596-25-000563","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2025-11-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Kaya Holdings appoints Richard D. Seay to board of directors effective Nov 25, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Richard D. Seay, 72, appointed to Kaya Holdings board effective Nov 25, 2025.","Mr. Seay is a licensed attorney with 47 years of practice in Florida state and federal courts.","He has served as state prosecutor, in-house counsel, and managerial roles at public companies.","Board cites his varied legal and business experience as rationale for the appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121361,"accession_number":"0001903596-25-000499","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2025-10-23T23:59:59+00:00","items":["5.01","8.01","9.01"],"status":"ready","headline":"Kaya Holdings converts $13.98M debt to equity; CVC gains 56.19% voting control","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued 642,868,838 shares to satisfy $13,979,148 of debt, converting over 90% of existing debt into equity.","CVC International received 581,914,466 shares converting $11,638,289 in notes, now holds 56.19% voting power – change in control.","Company plans to develop a Digital Asset Treasury Company (DATCO) via joint ventures with cryptocurrency foundations, no definitive agreement yet.","Engaged Conduit Advisors (Thomas Gaffney) and Greentree Financial Group to assist in crypto treasury strategy and potential Nasdaq uplisting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":138018,"accession_number":"0001903596-25-000470","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2025-09-22T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kaya Holdings engages advisors for cryptocurrency subsidiary and digital asset treasury strategy","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Engaged Greentree Financial Group and Conduit Advisors to develop a new crypto operating subsidiary.","Plans to implement a Digital Assets Treasury (DAT) strategy and related cryptocurrency operations.","Will explore licensed crypto custody/trading in the US, Grand Cayman, and other jurisdictions.","Success depends on converting existing debt to equity and restructuring capital; no assurance given.","Thomas Gaffney (Conduit) has advised on billion-dollar crypto transactions with Polychain, VanEck, others."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155412,"accession_number":"0001903596-25-000211","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2025-04-28T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Kaya Holdings Director Carrie Schwarz Steps Down Effective April 24, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Carrie Schwarz stepped down as a director of Kaya Holdings, Inc. effective April 24, 2025.","The change was reported on Form 8-K filed with the SEC on April 28, 2025.","Kaya Holdings trades on the OTC market under ticker KAYS."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207375,"accession_number":"0001903596-24-000554","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2024-08-26T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Kaya Holdings' psilocybin treatment center covered by Portland TV station KATU","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Company launched The Sacred Mushroom psilocybin treatment center in Portland, Oregon.","Local news story broadcast by KATU on August 25, 2024, details the center's operations.","No financial or operational metrics disclosed; promotional disclosure only."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207374,"accession_number":"0001903596-24-000552","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2024-08-22T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"Kaya Holdings increases authorized common shares from 500M to 1.5B","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Authorized shares increased to 1.5 billion from 500 million.","Amendment filed with Delaware Secretary of State on August 20, 2024.","No stated reason; likely to enable future financing or acquisitions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207373,"accession_number":"0001903596-24-000406","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2024-07-10T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kaya Holdings announces grand opening of The Sacred Mushroom psilocybin center in Portland, Oregon on July 5, 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Craig Frank will be the first guest to receive psilocybin treatment at the center.","The center is licensed and aims to treat PTSD, depression, anxiety, addiction, and other mental health disorders.","Company among few legally licensed to offer psilocybin treatments in Oregon.","Opening follows 18 months of preparation; center is now scheduling qualified guests."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224780,"accession_number":"0001903596-24-000380","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2024-06-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kaya Holdings opens The Sacred Mushroom psilocybin treatment center in Portland, accepting appointments","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Majority-owned subsidiary Fifth Dimension Therapeutics begins accepting appointments at The Sacred Mushroom in Portland, Oregon.","11,000 sq ft facility on 7th floor offers customized psychedelic experiences via proprietary 'Synergy by Design'.","Facility targets mental health conditions including PTSD, anxiety, trauma, and addictions; also offers group and corporate events.","U.S. behavioral health market was $83B in 2022, projected to exceed $136B by 2032 per Precedence Research.","CEO Craig Frank calls opening an important milestone for KAYS."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224779,"accession_number":"0001903596-24-000286","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2024-05-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Kaya Holdings awarded Oregon psilocybin service center license; first guests within 30 days","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Oregon Health Authority licenses KAYS to operate The Sacred Mushroom psilocybin treatment center in Portland.","Facility in historic Falcon Building spans ~11,000 sq ft with private rooms, activity zones, indoor garden.","KAYS subsidiary Fifth Dimension Therapeutics will operate center; first guests expected within 30 days.","CEO Craig Frank: company well positioned to become leader in psychedelic 'delivery of care'.","Precedence Research: U.S. behavioral health market from $83B (2022) to $136B by 2032."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261455,"accession_number":"0001903596-23-000929","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2023-11-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Kaya Holdings CEO discusses upcoming psilocybin treatment center in podcast","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["CEO Craig Frank and consultant Dave Jones feature on Investor Ideas Potcast about The Sacred Mushroom center.","Treatment center located on 11,000 sq ft top floor of Falcon Building in downtown Portland, Oregon.","Company plans to use natural psilocybin and psilocin, avoiding lengthy FDA process.","Offers both private and group experiences, including microdosing options at lower prices.","Kaya Holdings is a fully reporting OTC listed company (KAYS) with cannabis and psychedelic operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261454,"accession_number":"0001903596-23-000845","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Kaya Holdings unveils The Sacred Mushroom psilocybin center in Portland, Oregon","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["KAYS unveils The Sacred Mushroom, an 11,000 sq ft psilocybin center in Portland, Oregon.","Company claims it is the first U.S. public company to operate a psilocybin center.","Center will feature private treatment rooms, group sessions, yoga, and sensation rooms.","Launch subject to final Oregon Health Authority licensing and securing financing.","Project is under majority-owned subsidiary Fifth Dimension Therapeutics."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261453,"accession_number":"0001903596-23-000804","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2023-10-23T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"KAYS closes additional $600K non-dilutive bridge financing for Oregon psilocybin center","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Total bridge financing since June 2023 is $600K: $100K short-term due Mar 15, 2023, $500K repayable from 10% of quarterly revenues, balance due Jun 30, 2025.","Funds are non-dilutive, not convertible into stock, and carry no commissions or fees.","Company expects to submit Oregon Health Authority license application in 30 days and open The Sacred Mushroom facility within 90 days of approval.","The 11,000 sq ft facility will include a microdosing café, private treatment rooms, group areas, and activity zones aiming for lower pricing than competitors.","KAYS believes it is the only U.S. public company pursuing an OHA psilocybin treatment center license."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261452,"accession_number":"0001903596-23-000763","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2023-10-03T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kaya Holdings secures 11,000 sq ft Portland lease for The Sacred Mushroom psilocybin treatment center","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Leased premium space on top floor of Falcon Building in Portland, OR for planned psilocybin treatment center.","Facility to include microdosing café, private treatment rooms, group sessions, yoga, and art expression areas.","OHA licensing application planned within 30 days; zoning approved and a company VP already holds OHA facilitator license.","Launch remains subject to final OHA licensing and receipt of financing from investors.","Company aims to treat PTSD, addictions, eating disorders, and depression with affordable psilocybin therapy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296909,"accession_number":"0001903596-23-000407","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2023-05-15T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kaya Holdings issues shareholder update by email on May 12, 2023","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Company distributed a shareholder communications update via email on May 12, 2023.","The update is filed as Exhibit 99.1 to the Form 8-K.","No specific financial or operational details provided in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317279,"accession_number":"0001903596-23-000178","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2023-03-13T23:59:59+00:00","items":["2.01"],"status":"ready","headline":"Kaya Holdings sells Oregon property and retail cannabis store for ~$500k net proceeds","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Sold Lebanon, OR property for $769,500; net proceeds ~$302k after repaying loans and advances.","Sold Salem Retail Cannabis Store for $210,000 (less 6% commission); closing pending OLCC approval.","Combined net proceeds of ~$500k to fund working capital, Oregon Psilocybin business, and Florida Ketamine Clinic.","CVC International advanced $270k at 10% interest, convertible at $0.08/share, and released $500k mortgage lien.","Funds also earmarked for resolving three non-performing South Oregon store leases and franchising efforts."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317278,"accession_number":"0001903596-23-000145","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2023-02-21T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kaya Holdings subsidiary partners with Total Holistic Center to develop ketamine treatment model for clinic launch","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Fifth Dimension Therapeutics reaches agreement in principle with Total Holistic Center to develop ketamine treatment protocols.","Dr. Anya Temer will serve as Medical Director in Florida and develop treatment protocols for the planned clinics.","Initial co-location of 'Keta-Kaya' business within Total Holistic Center's offices in Boca Raton, Lake Worth, and Miami Beach.","This is the first step in launching Fifth Dimension Therapeutics Mind Care Clinics and Telehealth Services."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317277,"accession_number":"0001903596-23-000077","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2023-01-30T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kaya Holdings launches Fifth Dimension Therapeutics to enter psychedelic treatment market","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Fifth Dimension Therapeutics will target PTSD, addiction, eating disorders, and treatment-resistant mental health conditions.","Employee Bryan Arnold enrolled in Oregon Psilocybin Facilitator training; expected to complete and apply for license in April 2023.","Attorney Glenn E.J. Murphy joins FDT board to assist with pharma partnerships, IP, and funding opportunities.","Company cites $2.8B U.S. psychedelics market in 2021, forecast to reach $8.9B by 2029.","KAYS shifts cannabis focus to Europe while launching psychedelic 'mind care' operations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":352957,"accession_number":"0001903596-22-000432","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2022-07-07T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"Kaya Holdings' Greek joint venture receives installation license for 50K sq ft medical cannabis facility in Epidaurus","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Greek Kaya project received Cannabis Installation License for 50K sq ft medical cannabis facility in Epidaurus, Greece.","Facility includes 25K sq ft indoor cultivation, 15K sq ft EU-GMP extraction, 10K sq ft EU-GMP packing.","Management expects to reach agreement to purchase the property over coming months; license transferrable.","Company to use facility to cultivate and manufacture proprietary cannabis brands for Greek, German, EU markets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":407618,"accession_number":"0001721868-21-000939","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2021-12-29T23:59:59+00:00","items":["5.02","8.01","9.01"],"status":"ready","headline":"Kaya Holdings restructures preferred stock and debt; insiders gain 40% voting power","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Director Jordi Arimany resigned Sept. 8, 2021; Mitchell Chupak appointed, receiving 100k shares annually.","CEO Frank and BMN exchanged Series C Preferred (28.89 common per share, 16.4% combined voting) for Series D Preferred giving 40% voting power on as-converted basis.","Accrued compensation ($1.176M) reduced: each holder waived ~$338k, deferred $250k to Jan. 1, 2025, removing $676k liabilities and reclassifying $500k as long-term debt.","Exchange Agreement approved by independent directors on Dec. 26, 2021."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":407617,"accession_number":"0001721868-21-000721","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2021-10-27T23:59:59+00:00","items":["2.01","9.01"],"status":"ready","headline":"Kaya Holdings sells Oregon cannabis facility for $1.325M, cancels 1M shares","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale of Eugene, OR facility for $1.325M gross proceeds; funds cleared escrow.","Cash influx of ~$0.09 per share; proceeds to repay debt and fund expansion in Greece and Israel.","Issued and outstanding shares reduced by ~6.5% to 14.7M via cancellation of 1,006,671 shares.","Planned cultivation sites in Greece and Israel targeted to produce 600,000 pounds of cannabis annually."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":426636,"accession_number":"0001721868-21-000424","cik":1530746,"company_name":"Kaya Holdings, Inc.","ticker":"KAYS","form_type":"8-K","filed_at":"2021-07-28T23:59:59+00:00","items":["1.01","8.01","2.01","5.02","9.01"],"status":"ready","headline":"Kaya Holdings settles Sunstone dispute; shares cancelled, director resigns, warehouse cleared for sale","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Bruce Burwick surrendered 1,006,671 shares (6.4% of float) to KAYS for cancellation as part of settlement.","Burwick resigned from board and will receive $160,000 from sale of grow license; consulting fee $35,000/year for 4 years.","Company received clear title to Oregon warehouse; expects sale proceeds of ~$1.625M ($0.10/share) to fund U.S., Israel, Greece projects.","New corporate logo and website launched; updated info on Kaya Harmony, Kaya Shalvah, Kaya Kannabis projects."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":23201729.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}